Search

Your search keyword '"Aase, Hildegunn S."' showing total 21 results
Start Over Author "Aase, Hildegunn S."
21 results on '"Aase, Hildegunn S."'

3. Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer

Author

Yndestad, Synnøve, Engebrethsen, Christina, Herencia-Ropero, Andrea, Nikolaienko, Oleksii, Vintermyr, Olav K., Lillestøl, Reidun K., Minsaas, Laura, Leirvaag, Beryl, Iversen, Gjertrud T., Gilje, Bjørnar, Blix, Egil S., Espelid, Helge, Lundgren, Steinar, Geisler, Jürgen, Aase, Hildegunn S., Aas, Turid, Gudlaugsson, Einar G., Llop-Guevara, Alba, Serra, Violeta, Janssen, Emiel A.M., Lønning, Per E., Knappskog, Stian, and Eikesdal, Hans P.

Published
2023
Full Text
View/download PDF

6. Abstract P6-10-04: Homologous recombination deficiency across subtypes of primary breast cancer

Author

Engebrethsen, Christina, primary, Yndestad, Synnøve, additional, Herencia-Ropero, Andrea, additional, Nikolaienko, Oleksii, additional, Vintermyr, Olav Karsten, additional, Lillestøl, Reidun K., additional, Minsaas, Laura, additional, Leirvaag, Beryl, additional, Iversen, Gjertrud, additional, Gilje, Bjørnar, additional, Blix, Egil, additional, Espelid, Helge, additional, Lundgren, Steinar, additional, Geisler, Jürgen, additional, Vassbotn, Liv Jorunn, additional, Aase, Hildegunn S., additional, Aas, Turid, additional, Llop-Guevara, Alba, additional, Serra, Violeta, additional, Lønning, Per Eystein, additional, Knappskog, Stian, additional, and Eikesdal, Hans Petter, additional

Published
2023
Full Text
View/download PDF

7. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey

Author

Sardanelli, Francesco, Aase, Hildegunn S., Álvarez, Marina, Azavedo, Edward, Baarslag, Henk J., Balleyguier, Corinne, Baltzer, Pascal A., Beslagic, Vanesa, Bick, Ulrich, Bogdanovic-Stojanovic, Dragana, Briediene, Ruta, Brkljacic, Boris, Camps Herrero, Julia, Colin, Catherine, Cornford, Eleanor, Danes, Jan, de Geer, Gérard, Esen, Gul, Evans, Andrew, Fuchsjaeger, Michael H., Gilbert, Fiona J., Graf, Oswald, Hargaden, Gormlaith, Helbich, Thomas H., Heywang-Köbrunner, Sylvia H., Ivanov, Valentin, Jónsson, Ásbjörn, Kuhl, Christiane K., Lisencu, Eugenia C., Luczynska, Elzbieta, Mann, Ritse M., Marques, Jose C., Martincich, Laura, Mortier, Margarete, Müller-Schimpfle, Markus, Ormandi, Katalin, Panizza, Pietro, Pediconi, Federica, Pijnappel, Ruud M., Pinker, Katja, Rissanen, Tarja, Rotaru, Natalia, Saguatti, Gianni, Sella, Tamar, Slobodníková, Jana, Talk, Maret, Taourel, Patrice, Trimboli, Rubina M., Vejborg, Ilse, Vourtsis, Athina, and Forrai, Gabor

Published
2017
Full Text
View/download PDF

9. Additional file 2 of Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

Author

Venizelos, Andreas, Engebrethsen, Christina, Deng, Wei, Geisler, Jürgen, Geisler, Stephanie, Iversen, Gjertrud T., Aas, Turid, Aase, Hildegunn S., Seyedzadeh, Manouchehr, Steinskog, Eli Sihn, Myklebost, Ola, Nakken, Sigve, Vodak, Daniel, Hovig, Eivind, Meza-Zepeda, Leonardo A., Lønning, Per E., Knappskog, Stian, and Eikesdal, Hans P.

Abstract

Additional file 2. Study Protocol.

Published
2022
Full Text
View/download PDF

10. Additional file 4 of Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

Author

Venizelos, Andreas, Engebrethsen, Christina, Deng, Wei, Geisler, Jürgen, Geisler, Stephanie, Iversen, Gjertrud T., Aas, Turid, Aase, Hildegunn S., Seyedzadeh, Manouchehr, Steinskog, Eli Sihn, Myklebost, Ola, Nakken, Sigve, Vodak, Daniel, Hovig, Eivind, Meza-Zepeda, Leonardo A., Lønning, Per E., Knappskog, Stian, and Eikesdal, Hans P.

Abstract

Additional file 4: Table S1. Baseline characteristics. Table S2a. 6 most common serious adverse event (grade 2 or more). Table S2b. 8 most common adverse event (any grade). Table S3. Response to neoadjuvant epirubicin and docetaxel in stage II-III breast cancers, and outcome at surgery. Table S4. Treatment response. Table S5a. Pretreatment mutations and prediction to epirubicin treatment. Table S5b. Pretreatment mutations and prediction to docetaxel treatment. Table S6. Mutations in pretreatment biopsies and prediction to epirubicin treatment. Table S7. Mutations in post-epirubicin biopsies and prediction to docetaxel treatment.

Published
2022
Full Text
View/download PDF

11. Additional file 3 of Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

Author

Venizelos, Andreas, Engebrethsen, Christina, Deng, Wei, Geisler, Jürgen, Geisler, Stephanie, Iversen, Gjertrud T., Aas, Turid, Aase, Hildegunn S., Seyedzadeh, Manouchehr, Steinskog, Eli Sihn, Myklebost, Ola, Nakken, Sigve, Vodak, Daniel, Hovig, Eivind, Meza-Zepeda, Leonardo A., Lønning, Per E., Knappskog, Stian, and Eikesdal, Hans P.

Abstract

Additional file 3: Figure S1. CONSORT diagram for the Dose-Dense trial. Figure S2. Survival in the Dose-Dense trial after a minimum follow-up of five years or until death. Figure S3. Average sequencing coverage for each sample subject to whole exome sequencing (WES). Figure S4. Average sequencing coverage for each pretreatment tumor sample subject to amplicon-based sequencing. Figure S5. Oncoplot depicting the frequency of mutations in tumor samples undergoing whole exome sequencing (WES). Figure S6. Merged overview of copy number alterations (CNAs) in the sample set. Figure S7. Scatter plot showing Pearson correlation between copy number alterations (CNAs) and tumor mutation burden. Figure S8. Estimated contribution of mutational processes for each of the patients according to the classification by COSMIC. Figure S9. Graphical representation of clonal evolution from the pretreatment setting to post-epirubicin and post-docetaxel. Figure S10. Circos plots, coxcomb plots and heatmaps illustrating copy number logRs and mutation rVAFs pretreatment, post-epirubicin and post-docetaxel.

Published
2022
Full Text
View/download PDF

12. Additional file 1 of Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

Author

Venizelos, Andreas, Engebrethsen, Christina, Deng, Wei, Geisler, Jürgen, Geisler, Stephanie, Iversen, Gjertrud T., Aas, Turid, Aase, Hildegunn S., Seyedzadeh, Manouchehr, Steinskog, Eli Sihn, Myklebost, Ola, Nakken, Sigve, Vodak, Daniel, Hovig, Eivind, Meza-Zepeda, Leonardo A., Lønning, Per E., Knappskog, Stian, and Eikesdal, Hans P.

Abstract

Additional file 1. The Dose Dense Trial (Methods and Results) and Sequencing approaches.

Published
2022
Full Text
View/download PDF

18. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey

Author

Sardanelli, Francesco, Aase, Hildegunn S., Álvarez, Marina, Azavedo, Edward, Baarslag, Henk J., Balleyguier, Corinne, Baltzer, Pascal Andreas Thomas, Beslagic, Vanesa, Bick, Ulrich, Bogdanovic-Stojanovic, Dragana, Briediene, Ruta, Brkljacic, Boris, Camps Herrero, Julia, Colin, Catherine, Cornford, Eleanor, Danes, Jan, Geer, Gerard de, Esen, Gul, Evans, Andrew, Fuchsjäger, Michael H., Gilbert, Fiona J., Graf, Oswald, Hargaden, Gormlaith, Helbich, Thomas H., Heywang-Köbrunner, Sylvia H., Ivanov, Valentin, Jónsson, Ásbjörn, Kuhl, Christiane Katharina, Lisencu, Eugenia C., Luczynska, Elzbieta, Mann, Ritse M., Marques, Jose C., Martincich, Laura, Mortier, Margarete, Müller-Schimpfle, Markus, Ormandi, Katalin, Panizza, Pietro, Pediconi, Federica, Pijnappel, Ruud M., Pinker, Katja, Rissanen, Tarja, Rotaru, Natalia, Saguatti, Gianni, Sella, Tamar, Slobodníková, Jana, Talk, Maret, Taourel, Patrice, Trimboli, Rubina Manuela, Vejborg, Ilse, Vourtsis, Athina, Forrai, Gabor, Sardanelli, Francesco, Aase, Hildegunn S., Álvarez, Marina, Azavedo, Edward, Baarslag, Henk J., Balleyguier, Corinne, Baltzer, Pascal Andreas Thomas, Beslagic, Vanesa, Bick, Ulrich, Bogdanovic-Stojanovic, Dragana, Briediene, Ruta, Brkljacic, Boris, Camps Herrero, Julia, Colin, Catherine, Cornford, Eleanor, Danes, Jan, Geer, Gerard de, Esen, Gul, Evans, Andrew, Fuchsjäger, Michael H., Gilbert, Fiona J., Graf, Oswald, Hargaden, Gormlaith, Helbich, Thomas H., Heywang-Köbrunner, Sylvia H., Ivanov, Valentin, Jónsson, Ásbjörn, Kuhl, Christiane Katharina, Lisencu, Eugenia C., Luczynska, Elzbieta, Mann, Ritse M., Marques, Jose C., Martincich, Laura, Mortier, Margarete, Müller-Schimpfle, Markus, Ormandi, Katalin, Panizza, Pietro, Pediconi, Federica, Pijnappel, Ruud M., Pinker, Katja, Rissanen, Tarja, Rotaru, Natalia, Saguatti, Gianni, Sella, Tamar, Slobodníková, Jana, Talk, Maret, Taourel, Patrice, Trimboli, Rubina Manuela, Vejborg, Ilse, Vourtsis, Athina, and Forrai, Gabor

Abstract

EUSOBI and 30 national breast radiology bodies support mammography for population-based screening, demonstrated to reduce breast cancer (BC) mortality and treatment impact. According to the International Agency for Research on Cancer, the reduction in mortality is 40 % for women aged 50–69 years taking up the invitation while the probability of false-positive needle biopsy is <1 % per round and overdiagnosis is only 1–10 % for a 20-year screening. Mortality reduction was also observed for the age groups 40–49 years and 70–74 years, although with “limited evidence”. Thus, we firstly recommend biennial screening mammography for average-risk women aged 50–69 years; extension up to 73 or 75 years, biennially, is a second priority, from 40–45 to 49 years, annually, a third priority. Screening with thermography or other optical tools as alternatives to mammography is discouraged. Preference should be given to population screening programmes on a territorial basis, with double reading. Adoption of digital mammography (not film-screen or phosphor-plate computer radiography) is a priority, which also improves sensitivity in dense breasts. Radiologists qualified as screening readers should be involved in programmes. Digital breast tomosynthesis is also set to become “routine mammography” in the screening setting in the next future. Dedicated pathways for high-risk women offering breast MRI according to national or international guidelines and recommendations are encouraged.

Published
2016

19. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey

Author

Sardanelli, Francesco, primary, Aase, Hildegunn S., additional, Álvarez, Marina, additional, Azavedo, Edward, additional, Baarslag, Henk J., additional, Balleyguier, Corinne, additional, Baltzer, Pascal A., additional, Beslagic, Vanesa, additional, Bick, Ulrich, additional, Bogdanovic-Stojanovic, Dragana, additional, Briediene, Ruta, additional, Brkljacic, Boris, additional, Camps Herrero, Julia, additional, Colin, Catherine, additional, Cornford, Eleanor, additional, Danes, Jan, additional, de Geer, Gérard, additional, Esen, Gul, additional, Evans, Andrew, additional, Fuchsjaeger, Michael H., additional, Gilbert, Fiona J., additional, Graf, Oswald, additional, Hargaden, Gormlaith, additional, Helbich, Thomas H., additional, Heywang-Köbrunner, Sylvia H., additional, Ivanov, Valentin, additional, Jónsson, Ásbjörn, additional, Kuhl, Christiane K., additional, Lisencu, Eugenia C., additional, Luczynska, Elzbieta, additional, Mann, Ritse M., additional, Marques, Jose C., additional, Martincich, Laura, additional, Mortier, Margarete, additional, Müller-Schimpfle, Markus, additional, Ormandi, Katalin, additional, Panizza, Pietro, additional, Pediconi, Federica, additional, Pijnappel, Ruud M., additional, Pinker, Katja, additional, Rissanen, Tarja, additional, Rotaru, Natalia, additional, Saguatti, Gianni, additional, Sella, Tamar, additional, Slobodníková, Jana, additional, Talk, Maret, additional, Taourel, Patrice, additional, Trimboli, Rubina M., additional, Vejborg, Ilse, additional, Vourtsis, Athina, additional, and Forrai, Gabor, additional

Published
2016
Full Text
View/download PDF

20. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey

Author

Sardanelli, Francesco, Aase, Hildegunn S, Álvarez, Marina, Azavedo, Edward, Baarslag, Henk J, Balleyguier, Corinne, Baltzer, Pascal A, Beslagic, Vanesa, Bick, Ulrich, Bogdanovic-Stojanovic, Dragana, Briediene, Ruta, Brkljacic, Boris, Camps Herrero, Julia, Colin, Catherine, Cornford, Eleanor, Danes, Jan, De Geer, Gérard, Esen, Gul, Evans, Andrew, Fuchsjaeger, Michael H, Gilbert, Fiona J, Graf, Oswald, Hargaden, Gormlaith, Helbich, Thomas H, Heywang-Köbrunner, Sylvia H, Ivanov, Valentin, Jónsson, Ásbjörn, Kuhl, Christiane K, Lisencu, Eugenia C, Luczynska, Elzbieta, Mann, Ritse M, Marques, Jose C, Martincich, Laura, Mortier, Margarete, Müller-Schimpfle, Markus, Ormandi, Katalin, Panizza, Pietro, Pediconi, Federica, Pijnappel, Ruud M, Pinker, Katja, Rissanen, Tarja, Rotaru, Natalia, Saguatti, Gianni, Sella, Tamar, Slobodníková, Jana, Talk, Maret, Taourel, Patrice, Trimboli, Rubina M, Vejborg, Ilse, Vourtsis, Athina, and Forrai, Gabor

Subjects
Adult, Digital mammography, Breast Neoplasms, Middle Aged, 3. Good health, Europe, Middle East, Breast cancer, Digital breast tomosynthesis (DBT), Population-based screening, Recall rate, Humans, Mass Screening, Female, Early Detection of Cancer, Aged, Mammography
Abstract

UNLABELLED: EUSOBI and 30 national breast radiology bodies support mammography for population-based screening, demonstrated to reduce breast cancer (BC) mortality and treatment impact. According to the International Agency for Research on Cancer, the reduction in mortality is 40 % for women aged 50-69 years taking up the invitation while the probability of false-positive needle biopsy is

21. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, G

Author

Sardanelli, Francesco, Aase, Hildegunn S., Álvarez, Marina, Azavedo, Edward, Baarslag, Henk J., Balleyguier, Corinne, Baltzer, Pascal A., Beslagic, Vanesa, Bick, Ulrich, Bogdanovic-Stojanovic, Dragana, Briediene, Ruta, Brkljacic, Boris, Camps Herrero, Julia, Colin, Catherine, Cornford, Eleanor, Danes, Jan, De Geer, Gérard, Esen, Gul, Evans, Andrew, Fuchsjaeger, Michael H., Gilbert, Fiona J., Graf, Oswald, Hargaden, Gormlaith, Helbich, Thomas H., Heywang-Köbrunner, Sylvia H., Ivanov, Valentin, Jónsson, Ásbjörn, Kuhl, Christiane K., Lisencu, Eugenia C., Luczynska, Elzbieta, Mann, Ritse M., Marques, Jose C., Martincich, Laura, Mortier, Margarete, Müller-Schimpfle, Markus, Ormandi, Katalin, Panizza, Pietro, Pediconi, Federica, Pijnappel, Ruud M., Pinker, Katja, Rissanen, Tarja, Rotaru, Natalia, Saguatti, Gianni, Sella, Tamar, Slobodníková, Jana, Talk, Maret, Taourel, Patrice, Trimboli, Rubina M., Vejborg, Ilse, Vourtsis, Athina, and Forrai, Gabor

Subjects
3. Good health
Abstract

European radiology 27(7), 2737-2743 (2017). doi:10.1007/s00330-016-4612-z, Published by Springer, Berlin

Catalog

Books, media, physical & digital resources
See catalog results